Patents by Inventor Christopher Wagstrom

Christopher Wagstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070148091
    Abstract: Described are peptides and peptide mimetics that bind to and activate the thrombopoietin receptor. Such peptides and peptide mimetics are useful in methods for treating hematological disorders and particularly, thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions as well as in diagnostic methods employing labeled peptides and peptide mimetics.
    Type: Application
    Filed: December 13, 2006
    Publication date: June 28, 2007
    Inventors: William Dower, Ronald Barrett, Steven Cwirla, David Duffin, Christian Gates, Sherril Haselden, Larry Mattheakis, Peter Schatz, Christopher Wagstrom, Nicholas Wrighton
  • Publication number: 20060058240
    Abstract: Described are peptides and peptide mimetics that bind to and activate the thrombopoietin receptor. Such peptides and peptide mimetics are useful in methods for treating hematological disorders and particularly, thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions as well as in diagnostic methods employing labeled peptides and peptide mimetics.
    Type: Application
    Filed: October 20, 2005
    Publication date: March 16, 2006
    Inventors: William Dower, Ronald Barrett, Steven Cwirla, David Duffin, Christian Gates, Sherril Haselden, Larry Mattheakis, Peter Schatz, Christopher Wagstrom, Nicholas Wrighton
  • Publication number: 20050147962
    Abstract: Expression vectors for expressing multimeric polypeptides that are anchored on surfaces of genetically replicable packages are disclosed. The expression vectors include a vector segment encoding a polypeptide sequence having three polypeptide segments. One of the segments contains a cleavable peptide sequence cleavable by a proteolytic agent, and another segment has an anchoring peptide sequence for anchoring the multimeric polypeptide to the surface of the genetically replicable package. The cleavable peptide sequence is cleaved by the proteolytic agent and the first segment associates with the third segment to form the multimeric polypeptide. Also disclosed are methods, host cells, and kits employing the expression vectors.
    Type: Application
    Filed: November 19, 2003
    Publication date: July 7, 2005
    Inventors: Christopher Wagstrom, David Wilson, Steffen Nock